Terms: = Prostate cancer AND LDH AND Treatment
122 results:
1. Calotropis procera extract inhibits prostate cancer through regulation of autophagy.
Singh P; Dhole B; Choudhury J; Tuli A; Pandey D; Velpandian T; Gupta S; Chaturvedi PK
J Cell Mol Med; 2024 Mar; 28(6):e18050. PubMed ID: 38400579
[TBL] [Abstract] [Full Text] [Related]
2. Carvedilol induces pyroptosis through NLRP3-caspase1-ASC inflammasome by nuclear migration of NF-κB in prostate cancer models.
Zeng Y; Li MX; Wu SQ; Xu C
Mol Biol Rep; 2024 Jan; 51(1):201. PubMed ID: 38270665
[TBL] [Abstract] [Full Text] [Related]
3. Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy.
Handke A; Kesch C; Fendler WP; Telli T; Liu Y; Hakansson A; Davicioni E; Hughes J; Song H; Lueckerath K; Herrmann K; Hadaschik B; Seifert R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857524
[TBL] [Abstract] [Full Text] [Related]
4. A retrospective study: analysis of the relationship between lactate dehydrogenase and castration-resistant prostate cancer based on restricted cubic spline model.
Qiu R; Bu K; An H; Tao N
PeerJ; 2023; 11():e16158. PubMed ID: 37818332
[TBL] [Abstract] [Full Text] [Related]
5. TEAM Study: Upfront Docetaxel treatment in Patients With Metastatic Hormone-Sensitive prostate cancer: A Real-World, Multicenter, Retrospective Analysis.
Pisano C; Turco F; Arnaudo E; Fea E; Vanella P; Ruatta F; Filippi R; Brusa F; Prati V; Vana F; Mennitto A; Cattrini C; Vignani F; Dionisio R; Icardi M; Guglielmini P; Buosi R; Stevani I; Vormola R; Numico G; Depetris I; Comandone A; Gennari A; Airoldi M; Rossi M; Vellani G; Ortega C; Tucci M; Maio MD; Buttigliero C
Clin Genitourin Cancer; 2024 Apr; 22(2):56-67.e16. PubMed ID: 37798164
[TBL] [Abstract] [Full Text] [Related]
6. Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study.
Yamada Y; Sakamoto S; Sato K; Saito S; Kanesaka M; Rii J; Kurokawa K; Tachiwaki D; Fukui Y; Shibata H; Goto Y; Sazuka T; Imamura Y; Nakatsu H; Ichikawa T
Prostate; 2023 Dec; 83(16):1610-1618. PubMed ID: 37690087
[TBL] [Abstract] [Full Text] [Related]
7. The diagnostic effectiveness of serum sialic acid predicts both qualitative and quantitative prostate cancer in patients with prostate-specific antigen between 4 and 20 ng/mL.
Sun J; Yan L
Front Endocrinol (Lausanne); 2023; 14():1188944. PubMed ID: 37645415
[TBL] [Abstract] [Full Text] [Related]
8. Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer.
Tian A; Wu T; Zhang Y; Chen J; Sha J; Xia W
Cell Oncol (Dordr); 2023 Dec; 46(6):1855-1870. PubMed ID: 37610690
[TBL] [Abstract] [Full Text] [Related]
9. Predictors of outcomes of docetaxel treatment in de novo metastatic hormone-sensitive prostate cancer: A single-center cohort study.
Omrčen T; Eterović D; Jozić T; Vrdoljak E
Neoplasma; 2023 Jun; 70(3):476-484. PubMed ID: 37498062
[TBL] [Abstract] [Full Text] [Related]
10. treatment outcomes of radium-223 in patients with metastatic castration-resistant prostate cancer: An experience before National Health Insurance reimbursement in Taiwan.
Yu PH; Wei TT; Chang YH; Chung HJ; Huang EY; Lin TP; Huang WJ
J Chin Med Assoc; 2023 Aug; 86(8):756-761. PubMed ID: 37314313
[TBL] [Abstract] [Full Text] [Related]
11. Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant prostate cancer Patients Undergoing prostate-Specific Membrane Antigen-Directed Radioligand Therapy.
Hartrampf PE; Mihatsch PW; Seitz AK; Solnes LB; Rowe SP; Pomper MG; Kübler H; Bley TA; Buck AK; Werner RA
J Nucl Med; 2023 Aug; 64(8):1272-1278. PubMed ID: 37290794
[TBL] [Abstract] [Full Text] [Related]
12. Proapoptotic effect of nonthermal pulsed ultrasound on prostate cancer cells in a nude mouse model.
Maeda K; Shigemura K; Hayashi F; Kan Y; Hiraoka A; Yamaguchi A; Ueda M; Yang YM; Maeshige N; Ooya T; Nakano Y; Fujisawa M
Prostate; 2023 Sep; 83(12):1217-1226. PubMed ID: 37221965
[TBL] [Abstract] [Full Text] [Related]
13. Unveiling Antioxidant and Antiproliferative Effects of Prosopis juliflora Leaves against Human prostate cancer LNCaP Cells.
Khan F; Pandey P; Singh A; Upadhyay TK; AboElnaga SMH; Al-Najjar MAA; Saeed M; Kahrizi D
Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):20-27. PubMed ID: 37114313
[TBL] [Abstract] [Full Text] [Related]
14. Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapy.
Saito S; Sakamoto S; Higuchi K; Sato K; Zhao X; Wakai K; Kanesaka M; Kamada S; Takeuchi N; Sazuka T; Imamura Y; Anzai N; Ichikawa T; Kawakami E
Sci Rep; 2023 Apr; 13(1):6325. PubMed ID: 37072487
[TBL] [Abstract] [Full Text] [Related]
15. Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment-Japanese Ra-223 Therapy in prostate cancer using Bone Scan Index (J-RAP-BSI) Trial.
Kitajima K; Igeta M; Kuyama J; Kawahara T; Suga T; Otani T; Sugawara S; Kono Y; Tamaki Y; Seko-Nitta A; Ishiwata Y; Ito K; Toriihara A; Watanabe S; Hosono M; Miyake H; Yamamoto S; Narita M; Daimon T; Yamakado K
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1487-1498. PubMed ID: 36539508
[TBL] [Abstract] [Full Text] [Related]
16. Therapeutic plasma exchange in gastric signet ring cell carcinoma presenting as microangiopathic hemolytic anemia: A rare case report.
Candar O; Ekinci O; Merter M; Aslan M; Aras I
J Clin Apher; 2022 Dec; 37(6):606-610. PubMed ID: 36125111
[TBL] [Abstract] [Full Text] [Related]
17. Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis.
Yanagisawa T; Kawada T; Rajwa P; Mostafaei H; Motlagh RS; Quhal F; Laukhtina E; König F; Pallauf M; Pradere B; Karakiewicz PI; Nyirady P; Kimura T; Egawa S; Shariat SF
Urol Oncol; 2023 Apr; 41(4):177-191. PubMed ID: 35970698
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors.
Yazgan SC; Yekedüz E; Utkan G; Ürün Y
Prostate; 2022 Nov; 82(15):1456-1461. PubMed ID: 35899494
[TBL] [Abstract] [Full Text] [Related]
19. Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-
Zaccagna F; McLean MA; Grist JT; Kaggie J; Mair R; Riemer F; Woitek R; Gill AB; Deen S; Daniels CJ; Ursprung S; Schulte RF; Allinson K; Chhabra A; Laurent MC; Locke M; Frary A; Hilborne S; Patterson I; Carmo BD; Slough R; Wilkinson I; Basu B; Wason J; Gillard JH; Matys T; Watts C; Price SJ; Santarius T; Graves MJ; Jefferies S; Brindle KM; Gallagher FA
Radiol Imaging Cancer; 2022 Jul; 4(4):e210076. PubMed ID: 35838532
[TBL] [Abstract] [Full Text] [Related]
20. Pre- and intratherapeutic predictors of overall survival in patients with advanced metastasized castration-resistant prostate cancer receiving Lu-177-PSMA-617 radioligand therapy.
Wrenger R; Jüptner M; Marx M; Zhao Y; Zuhayra M; Caliebe A; Osmonov D; Lützen U
BMC Urol; 2022 Jul; 22(1):96. PubMed ID: 35788220
[TBL] [Abstract] [Full Text] [Related]
[Next]
